Condition
Geroscience clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Geroscience clinical trials that are recruiting, in United States. By phase: Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Keeping weight off after stopping GLP-1s using metformin with or without rapamycin or low‑dose naltrexone
This trial will test whether metformin alone or combined with low‑dose rapamycin or low‑dose naltrexone helps adults 40–85 maintain weight loss after they stop GLP‑1 medications.
-
GLYLO supplement to lower glycation and support healthy aging in postmenopausal women
This study tests whether taking GLYLO capsules for 24 weeks can lower harmful advanced glycation end products (AGEs) and improve metabolic and hormonal health in overweight or obese postmenopausal women aged 45–65 with mildly elevated HbA1c.
Related topics
Quick answers
How many Geroscience clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.